Lab
ST. Mary's Duluth Clinic Health System
ST. Mary's Duluth Clinic Health System was paid $4.97M by Medicaid between Jan 2018 and Dec 2024, across 122 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 20% of everything it billed.
33Billing provider infoST. MARY'S DULUTH CLINIC HEALTH SYSTEM
DULUTH, MN 55805
DULUTH, MN 55805
33aNPI1326078049assigned 07/05/2006
33bProvider typeClinical Medical Laboratory
28Total paid$4.97M
24GClaims288,633
24DCodes billed122
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Minnesota
Rank by total paid#12 of 69
Median peer was paid$48K
This provider vs. median103×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BOREN, KEVIN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28,993 | $307K | |
| 2019 | 29,523 | $414K | |
| 2020 | 29,698 | $519K | |
| 2021 | 47,727 | $946K | |
| 2022 | 52,233 | $1.17M | |
| 2023 | 53,842 | $858K | |
| 2024incomplete | 46,617 | $764K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 20% | 14,938 | 10,108 | $977K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 8.5% | 7,295 | 5,573 | $421K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 6.0% | 9,648 | 8,936 | $301K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 5.8% | 9,668 | 8,948 | $290K |
| 84443 | Thyroid stimulating hormone (TSH) | 5.4% | 19,097 | 18,180 | $270K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 4.8% | 12,641 | 8,769 | $236K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.6% | 7,229 | 6,804 | $178K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.2% | 7,598 | 7,120 | $162K |
| 81513 | 2.7% | 1,329 | 1,235 | $136K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2.4% | 3,845 | 3,608 | $121K |
| 80053 | Comprehensive metabolic panel | 2.0% | 10,897 | 9,696 | $97K |
| 88142 | 1.9% | 5,000 | 4,677 | $94K |
110 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 21,594 | $93K |
| 80061 | Lipid panel | 1.9% | 8,579 | $93K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.8% | 2,838 | $88K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.7% | 12,970 | $86K |
| 87507 | 1.5% | 261 | $77K | |
| 86780 | 1.5% | 6,977 | $72K | |
| 86803 | 1.2% | 4,930 | $62K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.1% | 8,265 | $57K |
| 82728 | 1.1% | 4,739 | $54K | |
| 85027 | <1% | 8,592 | $49K | |
| 82607 | <1% | 3,192 | $44K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,399 | $43K |
| 87340 | <1% | 4,360 | $40K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,310 | $39K |
| 87481 | <1% | 1,328 | $39K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,384 | $34K |
| 84466 | <1% | 3,167 | $34K | |
| 83655 | <1% | 2,435 | $31K | |
| 87522 | Neg quan hep c or qual rna | <1% | 761 | $31K |
| 87077 | <1% | 4,193 | $30K | |
| 84439 | <1% | 3,736 | $29K | |
| 87186 | <1% | 3,525 | $26K | |
| 83970 | <1% | 723 | $25K | |
| 84481 | <1% | 1,704 | $24K | |
| 87653 | <1% | 731 | $24K | |
| 86480 | <1% | 444 | $24K | |
| 82746 | <1% | 1,616 | $21K | |
| 83540 | <1% | 3,825 | $21K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 570 | $20K |
| 87660 | <1% | 950 | $17K | |
| 86762 | <1% | 1,294 | $17K | |
| 87480 | <1% | 950 | $16K | |
| 87510 | <1% | 948 | $16K | |
| 86481 | <1% | 171 | $15K | |
| 80076 | <1% | 2,021 | $15K | |
| 87632 | <1% | 103 | $12K | |
| 85610 | <1% | 3,176 | $11K | |
| 87070 | <1% | 1,339 | $11K | |
| 86038 | <1% | 937 | $10K | |
| 86618 | <1% | 696 | $10K | |
| 86140 | <1% | 2,140 | $10K | |
| 86706 | <1% | 1,047 | $10K | |
| 83735 | <1% | 1,627 | $9K | |
| 84460 | <1% | 1,855 | $9K | |
| 82784 | <1% | 794 | $7K | |
| 86364 | <1% | 757 | $7K | |
| 86704 | <1% | 683 | $7K | |
| 84146 | <1% | 424 | $7K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 199 | $7K |
| 86850 | <1% | 1,353 | $7K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 302 | $6K |
| 85004 | <1% | 3,412 | $6K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 84 | $6K |
| 84702 | <1% | 534 | $6K | |
| 87081 | <1% | 925 | $6K | |
| 84450 | <1% | 1,266 | $6K | |
| 80074 | <1% | 148 | $6K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 64 | $6K |
| 82565 | <1% | 1,092 | $5K | |
| 82670 | <1% | 216 | $5K | |
| 82043 | <1% | 1,007 | $5K | |
| 83001 | <1% | 309 | $5K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 82 | $4K |
| 83516 | <1% | 444 | $4K | |
| 83880 | <1% | 129 | $4K | |
| 84153 | <1% | 254 | $4K | |
| 86708 | <1% | 389 | $4K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 41 | $3K |
| 86431 | <1% | 660 | $3K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 66 | $3K |
| 81001 | <1% | 1,223 | $3K | |
| 82248 | <1% | 714 | $3K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 167 | $3K |
| 87205 | <1% | 722 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 62 | $3K |
| 85652 | <1% | 1,143 | $3K | |
| 86376 | <1% | 193 | $3K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 86 | $2K |
| 86696 | <1% | 120 | $2K | |
| 80164 | <1% | 169 | $2K | |
| 82570 | <1% | 370 | $2K | |
| 86900 | <1% | 605 | $2K | |
| 86901 | <1% | 580 | $2K | |
| 87631 | <1% | 15 | $1K | |
| 86695 | <1% | 119 | $1K | |
| 80069 | <1% | 173 | $1K | |
| 82947 | <1% | 377 | $1K | |
| 83690 | <1% | 185 | $1K | |
| 84100 | <1% | 291 | $1K | |
| 83721 | <1% | 139 | $1K | |
| 81003 | <1% | 556 | $1K | |
| 82274 | <1% | 76 | $1K | |
| 84156 | <1% | 335 | $1K | |
| 83525 | <1% | 100 | $955.04 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 12 | $645.60 |
| 80178 | <1% | 124 | $597.83 | |
| 84703 | <1% | 84 | $596.97 | |
| 84403 | <1% | 33 | $596.61 | |
| 85018 | <1% | 229 | $522.16 | |
| 83002 | <1% | 31 | $479.00 | |
| 82950 | <1% | 108 | $453.52 | |
| 81015 | <1% | 118 | $347.87 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 18 | $295.08 |
| 80159 | <1% | 27 | $292.15 | |
| 82977 | <1% | 34 | $202.48 | |
| 82533 | <1% | 13 | $178.20 | |
| 86709 | <1% | 15 | $161.75 | |
| 80177 | <1% | 14 | $131.69 | |
| 80175 | <1% | 17 | $106.45 | |
| 84550 | <1% | 15 | $58.63 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOREN, KEVIN (VP OF FINANCE)
Parent organizationST. MARY'S DULUTH CLINIC HEALTH SYSTEM
| Provider | Location | Paid |
|---|---|---|
| The Duluth Clinic, LTD | Duluth, MN | $51.60M |
| ST. Joseph's Medical Center | Brainerd, MN | $41.35M |
| SMDC Medical Center | Duluth, MN | $35.51M |
| ST Marys Medical Center | Duluth, MN | $20.98M |
| ST. Mary's Hospital of Superior | Superior, WI | $13.36M |
| ST Joseph's Medical Center | Baxter, MN | $7.23M |
| Deer River Healthcare Center, INC. | Deer River, MN | $4.57M |
| ST. Mary's Medical Center | Duluth, MN | $3.66M |
| ST. Joseph's Medical Center | Brainerd, MN | $3.25M |
| The Duluth Clinic, LTD | Virginia, MN | $2.82M |
| The Duluth Clinic, LTD | Duluth, MN | $2.66M |
| Northern Pines Medical Center | Aurora, MN | $1.72M |
| ST. Mary's Hospital of Superior | Superior, WI | $1.65M |
| Polinsky Medical Rehabilitation Center | Duluth, MN | $1.61M |
| Pine Medical Center | Sandstone, MN | $1.32M |
| The Duluth Clinic, LTD | Hermantown, MN | $1.30M |
| The Duluth Clinic LTD | Grand Rapids, MN | $1.18M |
| The Duluth Clinic, LTD | Duluth, MN | $1.13M |
| The Duluth Clinic, LTD | Ashland, WI | $1.07M |
| ST Mary's Hospital of Superior | Spooner, WI | $1.05M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.